M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis
Abstract Necroptosis has emerged as a novel and crucial player in acute and chronic liver diseases. Necroptotic cells lead to the release of DAMPs including S100A9, followed by the development of necroinflammation. We previously have documented the beneficial hepatoprotection conferred by M2-like ma...
Main Authors: | Li Bai, Ming Kong, Zhongping Duan, Shuang Liu, Sujun Zheng, Yu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-020-03378-w |
Similar Items
-
Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling
by: Li Bai, et al.
Published: (2022-09-01) -
Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B
by: Rui Wu, et al.
Published: (2018-04-01) -
Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
by: Bhawna Tomar, et al.
Published: (2020-06-01) -
Types of necroinflammation, the effect of cell death modalities on sterile inflammation
by: Anett Mázló, et al.
Published: (2022-05-01) -
Phenotypic switch of human and mouse macrophages and resultant effects on apoptosis resistance in hepatocytes
by: Li Bai, et al.
Published: (2019-04-01)